Cayman Islands Cannabis Advocates Push Legalization in Parliament
Reform campaigners presented decriminalization arguments to Cayman lawmakers as the British territory weighs cannabis policy changes.

A classic stone courthouse in Nanaimo, British Columbia, with Canadian flag, under clear blue sky.
Legislative Hearing Marks First Formal Legalization Push
Campaigners presented decriminalization proposals to members of the Cayman Islands Parliament in a public hearing on cannabis policy reform. The session, convened by the Legislative Assembly's social policy committee, heard testimony from local advocacy groups and medical professionals. No timeline for a vote has been announced.
The Cayman Islands Misuse of Drugs Law currently classifies cannabis as a Schedule I controlled substance. Possession carries penalties of up to one year imprisonment and a CI$10,000 fine (US$12,000). Cultivation and distribution offenses? Up to 10 years.
Economic and Criminal Justice Arguments Dominate Testimony
Advocates cited potential tax revenue and reduced incarceration costs as primary justifications for legalization. Testimony emphasized the territory's dependence on tourism revenue and the opportunity to capture cannabis spending from visitors, according to Cayman News Service reporting from the hearing.
Key arguments presented by reform campaigners:
- Estimated CI$15-20 million in annual tax revenue from regulated adult-use sales
- Reduction in law enforcement and incarceration costs tied to cannabis arrests
- Alignment with shifting regional policy — Jamaica decriminalized in 2015, Trinidad and Tobago debated legalization in 2019
- Medical access expansion for conditions including chronic pain and PTSD
The government hasn't released official projections on potential revenue or enforcement savings.
British Oversight Complicates Reform Path
As a British overseas territory, the Cayman Islands must secure approval from the UK Foreign Office for any drug-law changes that conflict with international treaty obligations. The 1961 UN Single Convention on Narcotic Drugs, to which the UK is a signatory, prohibits recreational cannabis legalization.
Bermuda passed a cannabis legalization bill in 2022, but the UK government blocked its implementation, citing treaty conflicts. The Cayman Islands would face the same approval process. The UK Foreign Office hasn't issued a statement on the Cayman hearing.
For full background on Caribbean cannabis reform efforts, see the CannIntel topic hub on Cayman Islands legalization.
What happens next? Unclear. The Legislative Assembly hasn't scheduled a committee vote or announced plans to draft legislation.
Frequently asked questions
What is the current legal status of cannabis in the Cayman Islands?
Cannabis is classified as a Schedule I controlled substance under the Misuse of Drugs Law. Possession carries penalties up to one year imprisonment and CI$10,000 fines. Cultivation and distribution offenses carry sentences up to 10 years.
Do the Cayman Islands need UK approval to legalize cannabis?
Yes. As a British overseas territory, the Cayman Islands must secure approval from the UK Foreign Office for drug-law changes that conflict with international treaty obligations, including the 1961 UN Single Convention on Narcotic Drugs.
How much tax revenue could cannabis legalization generate in the Cayman Islands?
Reform advocates estimate CI$15-20 million in annual tax revenue from regulated adult-use cannabis sales, though the government has not released official projections.
Has any other British overseas territory legalized cannabis?
No. Bermuda passed a legalization bill in 2022, but the UK government blocked its implementation, citing conflicts with the 1961 UN Single Convention on Narcotic Drugs.
When will the Cayman Islands vote on cannabis legalization?
No timeline has been announced. The Legislative Assembly held a public hearing on September 8, 2026, but has not scheduled a committee vote or announced plans to draft legislation.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Nebraska Supreme Court Upholds Cannabis Legalization Ballot Measures
State's highest court clears the way for November vote on medical and recreational cannabis after rejecting challenge.

GOP Majority Leader Calls Marijuana 'Gateway Drug' Amid Trump Rescheduling
House Majority Leader reaffirms opposition to cannabis reform as DEA moves toward Schedule III reclassification.

California ABC Finds 99% Compliance in 23,667 Hemp, Kratom Inspections
State regulators removed 7,403 products across 158 violations during site visits to alcohol-licensed retailers.
More from the newsroom

Endovia Pursues FDA Veterinary Approval for Cannabinoid Drug Targeting Dogs
The cannabis company is betting on canine cancer and chronic pain treatments to unlock FDA approval in the companion-animal market.

Canopy Growth Launches Two New Cannabis Formats in Australia
The Canadian MSO debuts flower and oil products through its Spectrum Therapeutics brand in the Australian medical market.

Grown Rogue Launches Cannabis Cultivation Operations in Minnesota
Oregon-based MSO enters Minnesota's adult-use market with new cultivation facility as state transitions from medical-only program.